Tatva Chintan Pharma Chem (NSE:TATVA) EPS (Basic): ₹17.98 (TTM As of Mar. 2026)


NSE:TATVA Tatva Chintan Pharma Chem Ltd NSE:TATVA
80 GF Score
Price ₹1,206.20
GF Value ₹1,455.13
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is Tatva Chintan Pharma Chem EPS (Basic)?

Tatva Chintan Pharma Chem NSE:TATVA +1.20% 80 EPS (Basic) is ₹17.98 as of Mar. 2026. GuruFocus rates NSE:TATVA with a GF Score™ of 80/100 and a GF Value™ of ₹1,455.13 (Modestly Undervalued). The stock has 3 warning signs investors should review.

Tatva Chintan Pharma Chem's basic earnings per share (Basic EPS) for the three months ended in Mar. 2026 was ₹4.41. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Mar. 2026 was ₹17.98.

Tatva Chintan Pharma Chem's EPS (Diluted) for the three months ended in Mar. 2026 was ₹4.41. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was ₹17.98.

Tatva Chintan Pharma Chem's EPS without NRI for the three months ended in Mar. 2026 was ₹4.41. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Mar. 2026 was 17.98.

During the past 12 months, Tatva Chintan Pharma Chem's average EPS without NRIGrowth Rate was 636.90% per year. During the past 3 years, the average EPS without NRI Growth Rate was -6.10% per year. During the past 5 years, the average EPS without NRI Growth Rate was -26.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 8 years, Tatva Chintan Pharma Chem's highest 3-Year average EPS without NRI Growth Rate was 65.00% per year. The lowest was -62.00% per year. And the median was -6.10% per year.

Tatva Chintan Pharma Chem  (NSE:TATVA) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Tatva Chintan Pharma Chem EPS (Basic) Related Terms

Tatva Chintan Pharma Chem EPS (Basic) Historical Data

* Premium members only.

The historical data trend for Tatva Chintan Pharma Chem's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Tatva Chintan Pharma Chem EPS (Basic) Chart

Tatva Chintan Pharma Chem Annual Data
Trend Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
EPS (Basic)
Get a 7-Day Free Trial 44.59 20.52 13.26 2.44 17.98

Tatva Chintan Pharma Chem Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
EPS (Basic) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.44 2.84 4.24 6.49 4.41
NSE:TATVA
80GF Score
Tatva Chintan Pharma Chem Ltd NSE:TATVA
EPS (Basic) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Tatva Chintan Pharma Chem EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Tatva Chintan Pharma Chem's Basic EPS for the fiscal year that ended in Mar. 2026 is calculated as

Basic EPS (A: Mar. 2026 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(420.54-0)/23.389
=17.98

Tatva Chintan Pharma Chem's Basic EPS for the quarter that ended in Mar. 2026 is calculated as

Basic EPS (Q: Mar. 2026 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(103.21-0)/23.404
=4.41

EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹17.98

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EPS (Basic) →
What does a EPS (Basic) of ₹17.98 mean?
Tatva Chintan Pharma Chem (NSE:TATVA) has a EPS (Basic) of ₹17.98 as of Mar. 2026. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on Tatva Chintan Pharma Chem and its competitors.
Is Tatva Chintan Pharma Chem's EPS (Basic) too high?
Tatva Chintan Pharma Chem's current EPS (Basic) is ₹17.98. Overall, Tatva Chintan Pharma Chem has a GF Score™ of 80/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Tatva Chintan Pharma Chem's EPS (Basic) compare to LIN and SHW?
Tatva Chintan Pharma Chem's EPS (Basic) of ₹17.98 can be compared against companies in the Chemicals industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS (Basic) for a Chemicals company?
A good EPS (Basic) depends on the Chemicals industry context. However, EPS (Basic) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS (Basic) mean?
A high EPS (Basic) can signal that a stock is expensive relative to its fundamentals. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on Tatva Chintan Pharma Chem and its competitors. Tatva Chintan Pharma Chem's current EPS (Basic) is ₹17.98. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Tatva Chintan Pharma Chem stock overvalued right now?
Based on GuruFocus' analysis, Tatva Chintan Pharma Chem (NSE:TATVA) is currently considered Modestly Undervalued. The stock's GF Value™ is ₹1,455.13, compared to a current price of ₹1,206.20 — trading 17.1% below its estimated fair value. The current EPS (Basic) is ₹17.98. Tatva Chintan Pharma Chem's overall GF Score™ is 80/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS (Basic) calculated?
EPS (Basic) is calculated from a company's financial statements. For Tatva Chintan Pharma Chem (NSE:TATVA), the current EPS (Basic) is ₹17.98 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Tatva Chintan Pharma Chem (NSE:TATVA) Overvalued in 2026?

Based on GuruFocus' analysis, Tatva Chintan Pharma Chem stock appears to be undervalued. The current stock price of ₹1,206.20 is trading 17.1% below its estimated GF Value™ of ₹1,455.13. GuruFocus considers Tatva Chintan Pharma Chem to be Modestly Undervalued.

Key valuation signals for NSE:TATVA:

  • EPS (Basic): ₹17.98
  • GF Value™: ₹1,455.13 vs. price of ₹1,206.20 (17.1% below fair value)
  • GF Score™: 80/100 with 3 warning signs

No single metric tells the full story. See the NSE:TATVA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Tatva Chintan Pharma Chem Business Description

Other Exchanges 543321:India
Address Plot No. 353, Makarpura GIDC, Vadodara, GJ, IND, 390010
Tatva Chintan Pharma Chem Ltd is a specialty chemicals manufacturing company engaged in the manufacturing and selling of specialty chemicals, Pharma and Agro intermediates, Quaternary Compounds, and Quats. The company's product portfolio includes structure-directing agents, phase transfer catalysts, electrolyte salts for supercapacitor batteries, pharmaceutical and agrochemical intermediates and other specialty chemicals. The company sells its products in domestic as well as overseas markets, with the majority of revenue coming from overseas markets.
80GF Score

Get the complete analysis for NSE:TATVA

EPS (Basic) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹1,206.20
Price
₹1,455.13
GF Value